Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Morphic (MORF) Short Interest Ratio & Short Volume

Morphic logo

Morphic Short Interest Data

Morphic (MORF) has a short interest of 1.90 million shares. This marks a 13.10% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 1.27 million shares to cover all short positions.

Current Short Interest
1,900,000 shares
Previous Short Interest
1,680,000 shares
Change Vs. Previous Month
+13.10%
Dollar Volume Sold Short
$107.65 million
Short Interest Ratio
0.8 Days to Cover
Last Record Date
July 31, 2024
Outstanding Shares
50,094,000 shares
Percentage of Shares Shorted
3.79%
Today's Trading Volume
400 shares
Average Trading Volume
1,272,131 shares
Today's Volume Vs. Average
0%
Short Selling Morphic?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Morphic and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MORF Short Interest Over Time

MORF Days to Cover Over Time

MORF Percentage of Float Shorted Over Time

Morphic Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/20241,900,000 shares $107.65 million +13.1%N/A0.8 $56.66
7/15/20241,680,000 shares $93.96 million -71.8%N/A0.8 $55.93
6/30/20245,960,000 shares $203.06 million -5.4%N/A3.7 $34.07
6/15/20246,300,000 shares $166.64 million +2.1%N/A13.1 $26.45
5/31/20246,170,000 shares $187.38 million -0.2%N/A14.2 $30.37
5/15/20246,180,000 shares $186.82 million -3.7%N/A14.2 $30.23
4/30/20246,420,000 shares $175.07 million +2.7%N/A14.5 $27.27
4/15/20246,250,000 shares $184.44 million +5.9%N/A12.7 $29.51
3/31/20245,900,000 shares $207.68 million -3.9%N/A11.4 $35.20
3/15/20246,140,000 shares $212.14 million +1.8%N/A11.5 $34.55
2/29/20246,030,000 shares $222.81 million +2.2%N/A9.9 $36.95
2/15/20245,900,000 shares $228.04 million -2.2%N/A9.6 $38.65
1/31/20246,030,000 shares $191.09 million +4.3%N/A10.1 $31.69
1/15/20245,780,000 shares $160.63 million +3.4%N/A10 $27.79
12/31/20235,590,000 shares $161.44 million -5.9%N/A8.1 $28.88
12/15/20235,940,000 shares $184.14 million -7.9%N/A6.1 $31.00
11/30/20236,450,000 shares $152.87 million +5.6%N/A5.7 $23.70
11/15/20236,110,000 shares $142.24 million -6.6%N/A5.6 $23.28
10/31/20236,540,000 shares $130.47 million +20.4%N/A6.1 $19.95
10/15/20235,430,000 shares $117.45 million +10.6%N/A5.2 $21.63
9/30/20234,910,000 shares $112.49 million +51.5%N/A5.3 $22.91
9/15/20233,240,000 shares $172.43 million +14.1%N/A4.9 $53.22
8/31/20232,840,000 shares $156.43 million +8.4%N/A7 $55.08
8/15/20232,620,000 shares $139.91 million +10.6%N/A6 $53.40
7/31/20232,370,000 shares $134.45 million -10.9%6.6%5.2 $56.73
7/15/20232,660,000 shares $156.75 million +9.5%7.9%4.3 $58.93
6/30/20232,430,000 shares $139.31 million -3.2%7.2%3.9 $57.33
6/15/20232,510,000 shares $148.92 million +6.8%7.5%4 $59.33
5/31/20232,350,000 shares $135.13 million -9.6%7.3%4 $57.50
5/15/20232,600,000 shares $149.60 million +19.3%8.1%4.4 $57.54
4/30/20232,180,000 shares $103.03 million +19.1%6.7%3.7 $47.26
4/15/20231,830,000 shares $63.39 million +2.8%6.2%4.8 $34.64
3/31/20231,780,000 shares $67.00 million -27.6%6.1%4.8 $37.64
3/15/20232,460,000 shares $104.06 million +4.2%8.4%7.1 $42.30
2/28/20232,360,000 shares $100.35 million -1.7%8.1%7.9 $42.52
2/15/20232,400,000 shares $95.86 million -26.2%8.4%9 $39.94
1/31/20233,250,000 shares $106.37 million -6.3%11.1%13.4 $32.73
1/15/20233,470,000 shares $110.07 million -2.8%11.9%14.1 $31.72
12/30/20223,570,000 shares $95.50 million +2.9%12.2%14.9 $26.75
12/15/20223,470,000 shares $93.76 million No Change11.9%13.4 $27.02
We recommended Palantir in 2021, now we’re recommending this... (Ad)

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol
11/30/20223,470,000 shares $95.49 million -0.3%11.9%12.2 $27.52
11/15/20223,480,000 shares $104.33 million -3.6%11.9%11.7 $29.98
10/31/20223,610,000 shares $101.12 million +0.3%12.8%11.6 $28.01
10/15/20223,600,000 shares $100.04 million +4.4%12.8%11.1 $27.79
9/30/20223,450,000 shares $97.64 million -4.2%12.3%10.3 $28.30
9/15/20223,600,000 shares $106.24 million +5.3%12.8%10.3 $29.51
8/31/20223,420,000 shares $94.12 million -1.7%12.2%9.3 $27.52
8/15/20223,480,000 shares $114.77 million -2.5%12.4%9.3 $32.98
7/31/20223,570,000 shares $94.50 million +1.7%13.4%8.9 $26.47
7/15/20223,510,000 shares $84.98 million +9.0%13.8%7.9 $24.21
6/30/20223,220,000 shares $69.87 million +3.5%12.7%7.1 $21.70
6/15/20223,110,000 shares $65.25 million -2.2%12.2%7.2 $20.98
5/31/20223,180,000 shares $74.54 million +16.1%12.7%8.3 $23.44
5/15/20222,740,000 shares $65.79 million +3.0%11.0%7.4 $24.01
4/30/20222,660,000 shares $80.62 million +39.3%N/A8.1 $30.31
4/15/20221,910,000 shares $81.65 million -9.5%N/A6.7 $42.75
3/31/20222,110,000 shares $84.72 million +5.0%N/A9.4 $40.15
3/15/20222,010,000 shares $75.94 million +6.9%N/A10 $37.78
2/28/20221,880,000 shares $74.94 million +3.3%7.9%9.5 $39.86
2/15/20221,820,000 shares $77.24 million +10.3%7.7%9.4 $42.44
1/31/20221,650,000 shares $70.01 million +16.2%7.1%9.4 $42.43
1/15/20221,420,000 shares $63.55 million +19.3%6.1%8.8 $44.75
12/31/20211,190,000 shares $56.38 million +7.2%5.5%8.1 $47.38
12/15/20211,110,000 shares $50.12 million +25.8%5.1%7.3 $45.15
11/30/2021882,100 shares $42.08 million -4.2%4.1%5.7 $47.70
11/15/2021920,600 shares $50.93 million -9.8%4.3%6.2 $55.32
10/29/20211,020,000 shares $58.65 million +7.0%4.8%6.5 $57.50
10/15/2021952,900 shares $55.98 million -9.3%4.6%5.8 $58.75
9/30/20211,050,000 shares $59.47 million +9.8%5.1%6.5 $56.64
9/15/2021956,600 shares $64.09 million +0.8%4.7%5.2 $67.00
8/31/2021948,700 shares $59.78 million -26.5%4.6%4.9 $63.01
8/13/20211,290,000 shares $78.48 million -10.4%6.3%5.7 $60.84
7/30/20211,440,000 shares $82.97 million +12.5%7.1%6.7 $57.62
7/15/20211,280,000 shares $73.77 million -2.3%6.4%6.2 $57.63
6/30/20211,310,000 shares $75.18 million +50.3%6.5%6.3 $57.39
6/15/2021871,500 shares $55.21 million +4.9%4.3%4.4 $63.35
5/28/2021830,500 shares $40.99 million +37.6%4.1%4.4 $49.36
5/14/2021603,400 shares $28.96 million +4.3%3.0%1.4 $48.00
4/30/2021578,800 shares $31.59 million -9.9%2.9%1.4 $54.57
4/15/2021642,300 shares $35.96 million +6.2%3.2%1.5 $55.98
3/31/2021604,700 shares $37.49 million -29.3%3.5%1.4 $62.00
3/15/2021854,900 shares $59.07 million -44.5%4.9%2 $69.09
2/26/20211,540,000 shares $50.59 million +2.7%8.9%3.8 $32.85
2/12/20211,500,000 shares $57.32 million -17.1%10.0%11.5 $38.21
1/29/20211,810,000 shares $60.82 million +29.3%13.3%13.3 $33.60
1/15/20211,400,000 shares $43.64 million +23.9%10.4%11.4 $31.17
12/31/20201,130,000 shares $37.93 million +20.9%8.5%10.4 $33.57
12/15/2020935,000 shares $31.43 million +3.1%7.1%10.6 $33.61
11/30/2020907,000 shares $29.10 million +15.9%7.0%11.9 $32.08
11/15/2020782,800 shares $23.26 million +1.1%6.1%12.1 $29.71
We recommended Palantir in 2021, now we’re recommending this... (Ad)

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol
10/30/2020774,700 shares $20.12 million +2.7%6.1%13.2 $25.97
10/15/2020754,300 shares $20.71 million -2.9%6.0%13.7 $27.45
9/30/2020776,700 shares $21.23 million +2.6%6.1%14.5 $27.34
9/15/2020757,200 shares $20.38 million +7.1%6.0%11.1 $26.91
8/31/2020706,900 shares $18.73 million +1.2%5.6%8.5 $26.50
8/14/2020698,800 shares $18.21 million -18.7%5.5%8 $26.06
7/31/2020859,800 shares $19.35 million -10.1%6.8%10.3 $22.51
7/15/2020956,700 shares $23.67 million -2.6%7.6%11.8 $24.74
6/30/2020982,500 shares $26.43 million +75.6%7.8%12.1 $26.90
6/15/2020559,600 shares $12.40 million +24.8%4.5%7.9 $22.15
5/29/2020448,400 shares $9.45 million +0.0%3.7%6.1 $21.08
5/15/2020448,200 shares $6.86 million +3.1%3.7%5.7 $15.30
4/30/2020434,900 shares $5.92 million +7.5%1.9%3.9 $13.61
4/15/2020404,500 shares $5.36 million -27.3%3.3%3.3 $13.26
3/31/2020556,300 shares $8.32 million +55.7%4.5%4.4 $14.96
3/13/2020357,400 shares $5.51 million +6.3%2.9%3.4 $15.41
2/28/2020336,100 shares $4.03 million +15.5%2.7%3.3 $12.00
2/14/2020291,000 shares $4.48 million -10.4%2.4%3 $15.41
1/31/2020324,600 shares $5.09 million -47.5%2.9%3.9 $15.67
1/15/2020618,000 shares $12.17 million -6.0%5.5%10.7 $19.69
12/31/2019657,300 shares $12.46 million +96.1%5.8%12.3 $18.96

MORF Short Interest - Frequently Asked Questions

What is Morphic's current short interest?

Short interest is the volume of Morphic shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 1,900,000 shares of MORF short. Learn More on Morphic's current short interest.

What is a good short interest ratio for Morphic?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MORF shares currently have a short interest ratio of 1.0. Learn More on Morphic's short interest ratio.

Is Morphic's short interest increasing or decreasing?

Morphic saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 1,900,000 shares, an increase of 13.1% from the previous total of 1,680,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Morphic's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Morphic: Vaxcyte, Inc. (8.85%), Qiagen (1.68%), Intra-Cellular Therapies, Inc. (1.64%), Roivant Sciences Ltd. (12.55%), Ascendis Pharma A/S (6.21%), Revolution Medicines, Inc. (9.61%), Lantheus Holdings, Inc. (6.73%), Nuvalent, Inc. (12.26%), Blueprint Medicines Co. (6.60%), Elanco Animal Health Incorporated (3.15%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.45 billion), Moderna, Inc. ($2.69 billion), Royal Caribbean Cruises Ltd. ($2.55 billion), Paychex, Inc. ($2.13 billion), Rivian Automotive, Inc. ($1.96 billion), Onsemi ($1.94 billion), Tractor Supply ($1.84 billion), Enphase Energy, Inc. ($1.77 billion), Chesapeake Energy Co. ($1.69 billion), and International Paper ($1.54 billion). View all of the most shorted stocks.

What does it mean to sell short Morphic stock?

Short selling MORF is an investing strategy that aims to generate trading profit from Morphic as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Morphic?

A short squeeze for Morphic occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MORF, which in turn drives the price of the stock up even further.

How often is Morphic's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MORF, twice per month. The most recent reporting period available is July, 31 2024.




This page (NASDAQ:MORF) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners